Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) in Meningococcal Vaccine-Naïve Participants across a Broad Age Range (2-55 Years) in Japan: a Phase III Randomized Study.
Jpn J Infect Dis
; 76(3): 174-182, 2023 May 24.
Article
in En
| MEDLINE
| ID: mdl-36724939
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Meningococcal Vaccines
/
Meningococcal Infections
/
Neisseria meningitidis
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Jpn J Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2023
Document type:
Article
Affiliation country:
Japón
Country of publication:
Japón